Alterations in the Gut Microbiota Composition in Obesity with and without Type 2 Diabetes: A Pilot Study
Xiaojing Wang,Qinli Guo,Zhaoxiang Liu,Yanlei Wang,Chenxiang Cao,Lixia Jin,Caihong Li,Jianzhong Xiao,Wenhui Zhao
DOI: https://doi.org/10.2147/dmso.s477494
2024-10-25
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Xiaojing Wang, Qinli Guo, Zhaoxiang Liu, Yanlei Wang, Chenxiang Cao, Lixia Jin, Caihong Li, Jianzhong Xiao, Wenhui Zhao Department of Endocrinology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, People's Republic of China Correspondence: Wenhui Zhao, Department of Endocrinology, Beijing Tsinghua Changgung Hospital, LiTang Lu No. 168, Chang Ping District, Beijing, 102218, People's Republic of China, Tel +86-13810719795, Email Purpose: Obesity has become a major public health concern worldwide, increasing the risk of T2DM. Growing evidence indicates gut microbiota dysbiosis is related to metabolic disorders. We aimed to firstly investigate the compositional and functional features of the gut microbiome between obesity with and without T2DM in the Chinese population. Methods: A total of 32 obese individuals accompanied with T2DM and 18 age and gender-matched obesity with normal glucose tolerance (NGT) were enrolled. Fecal samples were collected, and the gut microbiota profile was determined using the Illumina MiSeq platform based on V3-V4 bacterial 16S rRNA gene. Results: Compared with obesity- NGT, obesity-T2DM showed a significantly higher alpha diversity. Principal coordinates analysis based on both Bray-Curtis distance and weighted Unifrac revealed that the global microbial composition was significantly different between the two groups (P = 0.007 and P = 0.005, respectively). At the phylum level, Obesity-T2DM patients exhibited a significant decrease in Bacteroidetes , and a pronounced increase in Firmicutes . Regarding the genus level, Bacteroides and Escherichia-Shigella were found to increase considerably, while Prevotella_9 and Sutterella had an evident decrease in Obesity-T2DM. Furthermore, Spearman correlation analysis revealed that Prevotella_9 and Sutterella were negatively associated with HbA1c and fasting blood glucose. Conclusion: We found clear differences in the gut microbiota composition in obesity-T2DM compared with obesity-NGT. Obesity accompanied with T2DM may aggravate the obesity-associated gut microbiota, and gut microbiota is expected to be a promising novel intervention target for obese management. However, larger sample size and more in-depth taxonomic identification studies are warranted. Keywords: gut microbiota, obesity, type 2 diabetes The prevalence of obesity is increasing dramatically worldwide in adults and children, and obesity has become a major public health concern. 1 With the rapid socioeconomic development and lifestyle changes in China, the number of obesity has more than quadrupled during the past four decades. 2 The most recent national investigation reported that 16.4% of Chinese adults were obese. 2 There is no question that obesity, which predominantly increases the risk of type 2 diabetes mellitus (T2DM), cardiovascular disease, stroke, and cancers, poses a significant burden for the health-care system. 3 Obesity is caused by an imbalance between energy intake and expenditure. Notably, excessive energy and fat accumulation induce a low-grade chronic inflammation, an important driver of T2DM resulting from progressive loss of β-Cell insulin secretion and insulin resistance. 4,5 However, not all obese individuals develop T2DM. Growing evidence has indicated that gut microbiota dysbiosis is related to a wide variety of metabolic disorders, including obesity and T2DM. 6 Intestinal microbiota regulate host glucose metabolism by producing metabolically active products such as short-chain fatty acids (SCFAs) and bile acids. 7 Additionally, lipopolysaccharide (LPS), a component of the cell walls of gram-negative bacteria, is intimately involved in the inflammatory process by activating the TLR-4/NF-κB signal pathway. 8 Microbiota abnormalities elevate intestinal permeability, allowing LPS translocation to induce systemic inflammation and glucose metabolic dysfunction. 7,9 A meta-analysis also showed significant differences in gut microbiome composition in obese versus non-obesity adults. 10 Furthermore, fecal microbiota transplantation from obese increases the risk of hyperglycemia. 11 Together, these observations suggest that the gut microbiome may play a crucial role in the development of obesity-associated T2DM. In contrast, a study from Germany population found that the gut microbiome was not significantly different between obesity with and without T2DM. 12 These inconsistent results highlighted the importance of exploring gut microbiome in populations with different ethnicities and dietary habits. 13 As such, evidence regarding the gut microbiota disturbance in o -Abstract Truncated-
endocrinology & metabolism